Public Accountability and Sunshine Healthcare Regulation
Health Care Analysis 19 (4):352-364 (2011)
| Abstract | The lack of economic sustainability of most healthcare systems and a higher demand for quality and safety has contributed to the development of regulation as a decisive factor for modernisation, innovation and competitiveness in the health sector. The aim of this paper is to determine the importance of the principle of public accountability in healthcare regulation, stressing the fact that sunshine regulation—as a direct and transparent control over health activities—is vital for an effective regulatory activity, for an appropriate supervision of the different agents, to avoid quality shading problems and for healthy competition in this sector. Methodologically, the authors depart from Kieran Walshe’s regulatory theory that foresees healthcare regulation as an instrument of performance improvement and they articulate this theory with the different regulatory strategies. The authors conclude that sunshine regulation takes on a special relevance as, by promoting publicity of the performance indicators, it contributes directly and indirectly to an overall improvement of the healthcare services, namely in countries were citizens are more critical with regard to the overall performance of the system. Indeed, sunshine regulation contributes to the achievement of high levels of transparency, which are fundamental to overcoming some of the market failures that are inevitable in the transformation of a vertical and integrated public system into a decentralised network where entrepreneurialism appears to be the predominant culture. | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,705 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesJack High (1993). Self‐Interest and Responsive Regulation. Critical Review 7 (2-3):181-192.
Patrick L. Taylor (2009). Scientific Self-Regulation—so Good, How Can It Fail? Science and Engineering Ethics 15 (3).
Bärbel R. Dorbeck-Jung (2007). What Can Prudent Public Regulators Learn From the United Kingdom Government's Nanotechnological Regulatory Activities? NanoEthics 1 (3).
Robert W. Crandall (1993). Regulation and the “Rights” Revolution: Can (Should) We Rescue the New Deal? Critical Review 7 (2-3):193-204.
A. Wendy Russell & Robert Sparrow (2008). The Case for Regulating Intragenic Gmos. Journal of Agricultural and Environmental Ethics 21 (2).
Toby Seddon (2013). Regulating Health: Transcending Disciplinary Boundaries. Health Care Analysis 21 (1):43-53.
Lawrence J. Lad (2005). Paradoxes of Industry Self-Regulation. Proceedings of the International Association for Business and Society 16:259-262.
Alfons Bora (2010). Knowledge and the Regulation of Innovation. Poiesis and Praxis 7 (1-2):73-86.
Patricia J. Arnold & Terrie C. Reeves (2006). International Trade and Health Policy: Implications of the GATS for US Healthcare Reform. Journal of Business Ethics 63 (4):313 - 332.
Runtian Jing & John L. Graham (2008). Values Versus Regulations: How Culture Plays its Role. Journal of Business Ethics 80 (4):791 - 806.
Sebastian Sethe & Alison Murdoch (forthcoming). Comparing the Burden: What Can We Learn by Comparing Regulatory Frameworks in Abortion and Fertility Services? Health Care Analysis.
Guilhermina Rego, Cristina Brandão, Helena Melo & Rui Nunes (2002). Distributive Justice and the Introduction of Generic Medicines. Health Care Analysis 10 (2):221-229.
Analytics
Monthly downloads |
Added to index2011-11-10Total downloads2 ( #232,628 of 549,528 )Recent downloads (6 months)1 ( #63,397 of 549,528 )How can I increase my downloads? |
My notes
Discussion
